Skip to main content
. 2021 Feb 4;23:1204–1216. doi: 10.1016/j.omtn.2021.01.030

Figure 2.

Figure 2

Characteristics of DIO mice fed with an HFD after 6 and 16 weeks

(A) Body weights of mice fed with an HFD for 6 and 16 weeks. (B) Relative fold changes of miR-200c in gingiva and WAT in mice fed with an HFD for 6 weeks. (C and D) Relative transcript level changes of noggin, Zeb1, IL-6, and IL-8 in gingival tissues and WAT in mice fed with an HFD for 6 weeks. (E) Relative fold changes of miR-200c in gingiva and WAT in mice fed with an HFD for 16 weeks. (F and G) Relative transcript change of noggin, Zeb1, IL-6, and IL-8 in gingival tissues and WAT in mice fed with an HFD for 16 weeks. (H) Concentrations of IL-6 in blood serum in mice fed with an HFD for 16 weeks. (I) Blood glucose concentrations of a GTT test in mice fed with an HFD for 16 weeks. ∗p < 0.05 versus wild-type (WT), n = 3–9.